
Sign up to save your podcasts
Or


Use code "CEMAG25" for 50% off at clarahealthcare.com
In this episode of WoundCasters, host Felix Boecker is joined by Maurice Lubetzki and Clément from CemagCare to explore a rarely discussed but deeply impactful challenge in wound care: malodorous wounds. The conversation centers on Cinesteam, a novel cinnamon-based secondary dressing designed not to mask odor, but to chemically bind and neutralize the volatile compounds responsible for it. What begins as a discussion of product innovation quickly becomes a broader conversation about patient dignity, caregiver burden, and quality of life.
The guests share the origin story behind Cinesteam, which began with a French oncology nurse confronting the daily reality of fungating and tumoral wounds. Through extensive research, testing, and collaboration with clinicians and patients, CemagCare developed a dressing that leverages pharmaceutical-grade Sri Lankan cinnamon to address odor at its source—even in heavily exudative wounds where traditional charcoal dressings often fail. Felix and the team dive into how the dressing works, when to use it, contraindications, and why odor should be treated as a symptom—not a side effect clinicians are forced to tolerate.
The episode also offers a candid look at the realities of bringing a new wound care product to market, including years-long R&D cycles, regulatory pathways in Europe versus the U.S., reimbursement challenges, and the importance of clinician-driven innovation. As CemagCare begins expanding access in the U.S., the discussion highlights the unmet need for solutions that prioritize dignity alongside healing—and why addressing odor can be transformative for patients, families, and care teams alike.
DISCLAIMER
The following podcast features a company discussing their product technology and offering a promotional discount to listeners. This content is for educational purposes only and does not constitute an endorsement or recommendation by Wound Care Today USA. Healthcare professionals should evaluate all products based on their clinical judgment. The views expressed by guests are their own and do not necessarily reflect the views of Wound Care Today USA.
By Wound Care Today USAUse code "CEMAG25" for 50% off at clarahealthcare.com
In this episode of WoundCasters, host Felix Boecker is joined by Maurice Lubetzki and Clément from CemagCare to explore a rarely discussed but deeply impactful challenge in wound care: malodorous wounds. The conversation centers on Cinesteam, a novel cinnamon-based secondary dressing designed not to mask odor, but to chemically bind and neutralize the volatile compounds responsible for it. What begins as a discussion of product innovation quickly becomes a broader conversation about patient dignity, caregiver burden, and quality of life.
The guests share the origin story behind Cinesteam, which began with a French oncology nurse confronting the daily reality of fungating and tumoral wounds. Through extensive research, testing, and collaboration with clinicians and patients, CemagCare developed a dressing that leverages pharmaceutical-grade Sri Lankan cinnamon to address odor at its source—even in heavily exudative wounds where traditional charcoal dressings often fail. Felix and the team dive into how the dressing works, when to use it, contraindications, and why odor should be treated as a symptom—not a side effect clinicians are forced to tolerate.
The episode also offers a candid look at the realities of bringing a new wound care product to market, including years-long R&D cycles, regulatory pathways in Europe versus the U.S., reimbursement challenges, and the importance of clinician-driven innovation. As CemagCare begins expanding access in the U.S., the discussion highlights the unmet need for solutions that prioritize dignity alongside healing—and why addressing odor can be transformative for patients, families, and care teams alike.
DISCLAIMER
The following podcast features a company discussing their product technology and offering a promotional discount to listeners. This content is for educational purposes only and does not constitute an endorsement or recommendation by Wound Care Today USA. Healthcare professionals should evaluate all products based on their clinical judgment. The views expressed by guests are their own and do not necessarily reflect the views of Wound Care Today USA.